1 Luca Arecco, MD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team, Brussels, Belgium; Abeid Omar, MD, Department of Clinical Oncology, Kenyatta University Teaching, Referral and Research Hospital (KUTRRH), Nairobi, Kenya; Luciana de Moura Leite, MD, Department of Medical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil; Kristina Janković, MD, Clinic of Oncology, University Clinical Center Nis, Nis, Serbia; Gabriella Gentile, MD, Department of Radiological, Oncological and Pathological Sciences, Sapienza-University of Rome, Rome, Italy; Mihaela Stana, MD, Department of Medical Oncology, Elysée Hospital, Alba Iulia, Romania; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; and Matteo Lambertini, MD, PhD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.